ACEA Biosciences

ACEA is a developer of cell analysis instruments for life science research and clinical diagnostics. Read more

CEO Avatar


James O’Connell

CEO Approval Rating










Missing a competitor? Contribute!

CST is perceived as one of ACEA Biosciences's biggest rivals. CST is headquartered in Danvers, Massachusetts, and was founded in 1999. CST operates in the Biotechnology industry. CST generates 2,305% the revenue of ACEA Biosciences.

Applied BioPhysics is one of ACEA Biosciences's top competitors. Applied BioPhysics is a Private company that was founded in 1991 in Troy, New York. Applied BioPhysics competes in the Health Care Technology field. Compared to ACEA Biosciences, Applied BioPhysics has 5 fewer employees.

Sphere Fluidics has been one of ACEA Biosciences's top competitors. Sphere Fluidics was founded in 2010 in Cambridge, England. Sphere Fluidics competes in the Health Care Equipment industry. Sphere Fluidics generates $4.6M more revenue than ACEA Biosciences.


Help the Owler community know more

Growth Score - 1/1

Is $5M a good estimate for ACEA Biosciences's revenue?

ACEA Biosciences Acquisitions

No recent acquisitions found related to ACEA Biosciences

ACEA Biosciences Funding History

Since ACEA Biosciences was founded in 2002, it has participated in 1 round of funding. In total ACEA Biosciences has raised $30.0M. ACEA Biosciences' funding round was on Nov 2015 for a total of $30.0M





Nov 2015

Lilly Asia Ventures

Since ACEA Biosciences was founded in 2002, it has participated in 1 round of funding. In total ACEA Biosciences has raised $30.0M. ACEA Biosciences' funding round was on Nov 2015 for a total of $30.0M

ACEA Biosciences Investments

No recent investments found related to ACEA Biosciences

ACEA Biosciences News

March 7, 2019BioPortfolio

ACEA Biosciences and PhysioStim Announce Partnership to Provide Comprehensive In Vitro Cardiac Safety Assessment Services

ACEA Biosciences and PhysioStim will work together to provide comprehensive in vitro cardiac safety a... See more »
March 1, 2019BioPortfolio

ACEA Presents xCELLigence Research Grant to Dr. Teresa Krabbe

German scientist will employ xCELLigence Real Time Cell Analysis RTCA technology to develop an oncoly... See more »
November 29, 2018BioPortfolio

ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery

Research Collaboration Aims to Revolutionize Treatment of Cancer through Efficient Production of High... See more »
November 15, 2018ChinaBio Today

Agilent Closes $250 Million Acquisition of ACEA, a US-China Lab Tools Maker

Agilent Technologies closed its $250 million acquisition of ACEA Biosciences, a San Diego-Hangzhou co... See more »
November 15, 2018BioPortfolio

ACEA Biosciences Inc Medical Equipment Deals and Alliances Profile Report Updated 15102018 Prices from USD $250

SummaryACEA Biosciences Inc ACEA is a biotechnology company that development and commercialization of... See more »
September 30, 2018BioPortfolio

Week in Review Agilent Pays $250 Million to Acquire ACEA and its Cell Therapy Analyzer

Deals and FinancingsACEA Biosciences a San DiegoHangzhou company that makes the xCELLigence® cell the... See more »

ACEA Biosciences Press Releases

May 1, 2018PRWeb

New High Performance 4-Laser Benchtop Flow Cytometer to be Launched by ACEA Biosciences at CYTO 2018

The NovoCyte Quanteon flow cytometer, a highly advanced benchtop instrument with 4 lasers and 25-colo... See more »
March 31, 2018Free Press Release 2

xCELLigence-based Cardiotoxicity Study Voted Paper of the Year

AstraZeneca's in vitro analysis of kinase inhibitor-induced cardiotoxicity receives Drug Discovery To... See more »
December 19, 2017Free Press Release 2

Real-Time Monitoring of Melanoma Cell Invasion Helps Scientists Elucidate Key Regulators of Metastasis

Using xCELLigence assay, the interaction between two membrane proteins is shown to modulate the trans... See more »
October 20, 2017PRWeb

Characterizing Bacteriophage-Derived Enzymes That Degrade Staphylococcus Biofilms

Employing the xCELLigence technology from ACEA Biosciences, a team of Spanish scientists have develop... See more »
July 28, 2017PR Newswire

Global Market for Cell-Based Assays - Expected to Increase from $17.1 Billion in 2016 to Nearly $28.4 Billion in 2021

DUBLIN, July 28, 2017 /PRNewswire/ -- The "Cell-based Assays: Technologies and Global Markets" report... See more »
December 7, 2016PRWeb

ACEA Biosciences Presents Efficacy and Safety Data From AC0010 Phase I/II Clinical Trial for Treatment of Advanced Non-Small Cell Lung Cancer at the WCLC 2016 Conference

Novel EGFR tyrosine kinase inhibitor AC0010 displays high efficacy, tolerability, and safety in phase... See more »
November 30, 2016PRWeb

New AC0010 Data to Be Presented

Clinical trial results for novel EGFR inhibitor AC0010 will be presented December 7th at World Confer... See more »

ACEA Biosciences Videos

June 4, 2019ACEA Biosciences Youtube Channel

"AAI 2019 Tech Talk - Ryan Duggan" on YOUTUBE

April 29, 2019ACEA Biosciences Youtube Channel

"NovoCyte Quanteon Flow Automation 3D Animation" on YOUTUBE

April 26, 2019ACEA Biosciences Youtube Channel

"Cancer Symposium 2019 Highlight Video" on YOUTUBE

April 10, 2019ACEA Biosciences Youtube Channel

"Checkpoint Inhibitor Research Challenges" on YOUTUBE

March 28, 2019ACEA Biosciences Youtube Channel

"xCELLigence RTCA ePacer" on YOUTUBE

Social Media

ACEA Biosciences Headquarters

6779 Mesa Ridge Road Suite 100

San Diego, California92121


Driving Directions »

Trending Companies

ACEA Biosciences Summary



ACEA is a developer of cell analysis instruments for life science research and clinical diagnostics. ACEA Biosciences was founded in 2002. ACEA Biosciences' headquarters is located in San Diego, California, USA 92121. It has raised 30.0M in 1 round. T...


ACEA Biosciences's CEO, James O’Connell, currently has an approval rating of 62%. ACEA Biosciences's primary competitors are CST, Applied BioPhysics & Sphere Fluidics.

Frequently Asked Questions about ACEA Biosciences

  1. When was ACEA Biosciences founded?

    ACEA Biosciences was founded in 2002
  2. Who is ACEA Biosciences's CEO?

    ACEA Biosciences's CEO is James O’Connell
  3. How much revenue does ACEA Biosciences generate?

    ACEA Biosciences generates $5M in revenue
  4. How much funding does ACEA Biosciences have?

    ACEA Biosciences has historically raised $30M in funding
  1. Where is ACEA Biosciences's headquarters?

    ACEA Biosciences's headquarters is in San Diego California, USA
  2. How many employees does ACEA Biosciences have?

    ACEA Biosciences has 25 employees
  3. What sector does ACEA Biosciences operate in?

    ACEA Biosciences is in Pharmaceuticals
  4. Who are ACEA Biosciences's competitors?

    ACEA Biosciences's top competitors are CST, Applied BioPhysics, Sphere Fluidics